Latest Report Available at Orbis research Biologics Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
Request sample copy of this report @ http://www.orbisresearch.com/contacts/request-sample/2084925 .
Pharmaceutical industry is engaged in the discovery, manufacturing and marketing of pharmaceutical drugs such as legal drugs, vaccines, biologics and a large number of medical devices such as infusion pump, pacemakers, prosthetics, implantable defibrillators etc. Pharmaceutical drugs and devices are subjected to various laws and regulations governing their patent, safety, and efficacy. On an elementary level pharmaceutical drugs are broadly classified into two categories: small molecules (non-biologics) and large molecules (biologics).
Large molecules are mostly made of cells or other living organisms and are used to produce therapeutic proteins or biological molecules. Drugs made up of large molecules are popularly known as biotech drugs, biologics or biopharmaceuticals. The major biologics blockbusters currently available in the market are Humira, Remicade, Enbrel, Avastin and Herceptin.
The global biologics market has increased over the years and projections are made that the market would grow at a steady pace in the next four years i.e. 2018-2022, particularly due to increasing biologics approval and growing incidence of chronic conditions among the aging population. The global biologics market is supported by various growth drivers such as increased availability of advanced diagnostics, raising auto-immune diseases, higher usage of monoclonal antibodies for the treatment of different diseases, advancement in healthcare & biotechnology, etc. Yet the market faces some challenges which are obstructing the growth of the market. Some of the major challenges faced by the industry are: high cost of biologics, lack of oral absorption, complex regulatory approval etc.
Browse Complete Report @ http://orbisresearch.com/reports/index/global-biologics-market-size-trends-and-forecast-2018-2022 .
Scope of the Report
The report entitled “Global Biologics Market: Size, Trends & Forecast (2018-2022)”, provides an in-depth analysis of the global biologics market with description of market sizing and growth. The analysis includes market by value, by segment and by region. It also provides a detailed analysis of biologics market in terms of manufacturing process, product-category and therapeutic areas as well.
The report includes a brief regional analysis of North America, Europe and China with their actual and forecasted market size. North America has the largest stake in the global biologics market over the years and is expected to maintain its position in the upcoming years also. Among the Asia countries, China is the largest market and has the potential to grow steadily over the forecasted period.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biologics market has also been forecasted for the years 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Abbvie Inc., Samsung Electronics (Samsung Biologics), F. Hoffmann La Roche and Amgen Inc. are some of the key players operating in the global biologics market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the respective companies are provided.
Samsung Electronics (Samsung Biologics)
F. Hoffmann La Roche
Purchase a copy of Biologics Market visit @ http://www.orbisresearch.com/contact/purchase/2084925 For more information contact email@example.com .
Some points From TOC:
- Executive Summary
2.1 Pharmaceutical Industry: An Overview
2.1.1 Segmentation of Pharmaceutical Industry (Drugs)
2.2 Biologics: An Overview
2.2.1 Biologics Definition
2.2.2 Biologics Medical Use
2.2.3 Difference between Chemical Drugs and Biologics
2.2.4 Key Biologics Product US/EU Expiry Date
2.3 Biologics Manufacturing Process
2.3.1 Biologics Manufacturing Process
2.4 Biologics Product-Category
2.4.1 Biologics Product-Category
- Global Market Analysis
3.1 Global Pharmaceuticals Market Analysis
3.1.1 Global Pharmaceuticals Market by Value
3.1.2 Global Pharmaceuticals Market by Segments
3.2 Global Biologics Market Analysis
3.2.1 Global Biologics Market by Value
3.2.2 Global Biologics Manufacturing Market by Value
3.2.3 Global Biologics Market by Product-Category
3.2.4 Global Biologics Market by Therapeutic Areas
3.2.5 Global Biologics Market by Region
3.2.6 Global Biologics Market Growth Outlook by Region
3.2.7 Global Biologics Manufacturing Market by Segments
3.3 Global Biologics Manufacturing Market: Segment Analysis
3.3.1 Global Bio CMO Market by Value
3.3.2 Global Biologics In-House Market by Value
3.4 Global Biologics Market: Product Analysis
3.4.1 Global Biologics Monoclonal Antibodies Market by Value
3.4.2 Global Biologics Recombinant Protein Market by Value
3.4.3 Global Biologics Vaccines Market by Value
3.4.4 Global Biologics Regenerative Medicines Market by Value
3.5 Global Biologics Market: Therapeutic Areas Analysis
3.5.1 Global Biologics Inflammatory Market by Value
3.5.2 Global Biologics Oncology and Immunomodulatory Market by Value
3.5.3 Global Biologics Endocrine Market by Value
3.5.4 Global Biologics Anti-Infectives Market by Value
For any enquires before buying, connect with us @ firstname.lastname@example.org
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115